20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2747 | Endothall | Others | |
Endothall is an effective protein phosphatase 2A (PP2A) inhibitor, exerting inhibitory effects on both PP2A and PP1, with IC50 values of 90 nM and 5 µM, respectively. It exhibits anticancer activity, making it suitable f... | |||
T9271 | RAD51-IN-1 | DNA/RNA Synthesis | |
Rad51-in-1 is a derivative of B02 and an effective inhibitor of Rad51. | |||
T2217 | Cephalomannine | Baccatin III | Microtubule Associated |
Cephalomannine (Baccatin III) is a taxol derivative obtained from Taxus yunnanensis with antitumor activity. | |||
T1478 | Ondansetron hydrochloride dihydrate | SN 307,NSC 665799,GR 38032,Ondansetron hydrochloride | 5-HT Receptor |
Ondansetron hydrochloride dihydrate (GR 38032) is a competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, a... | |||
T0132 | Etoposide | VP-16,VP-16-213 | Apoptosis , Mitophagy , Topoisomerase , Antibacterial , Antibiotic , Autophagy |
Etoposide (VP-16-213) is a topoisomerase II inhibitor that inhibits DNA synthesis by forming a complex with topoisomerase II and DNA (IC50=60.3 μM). Etoposide has antitumor activity and induces apoptosis and autophagy. | |||
T2047 | AG-1478 | AG1478,NSC 693255,Tyrphostin AG-1478 | EGFR , HCV Protease , Influenza Virus , HER , PDGFR |
AG-1478 (NSC-693255) (Tyrphostin AG-1478) is a selective EGFR inhibitor. | |||
T16871 | Semustine | DNA Alkylator/Crosslinker | |
Semustine, a DNA alkylating agent, is a cancer chemotherapy compound that is nephrotoxic in patients with malignant melanoma receiving adjuvant chemotherapy for the adjuvant treatment of leukemia. | |||
T6431 | Levoleucovorin Calcium | Calcium Levofolinate,CL307782 | Others , Antifolate |
Levoleucovorin Calcium (CL307782), a calcium salt of the folinic acid, is used in cancer chemotherapy as an adjuvant. | |||
T28187 | Nonabine | ||
Nonabine is a compound with strong antiemetic properties that can be used to prevent nausea and vomiting associated with cancer chemotherapy. | |||
T1755 | LY2090314 | GSK-3 | |
LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, a... | |||
T6616 | Ondansetron hydrochloride | SN 307,Ondansetron HCl,Emeset,GR 38032 HCl,NSC 665799,Zofran | 5-HT Receptor |
Ondansetron hydrochloride (Zofran) is a serotonin 5-HT3 receptor antagonist, used to prevent nausea and vomiting caused by cancer chemotherapy, and radiation therapy. | |||
T1042 | Granisetron hydrochloride | BRL 43694A,Granisetron HCl | 5-HT Receptor |
Granisetron hydrochloride (Granisetron HCl) is a serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients. | |||
T21876 | DC_AC50 | Apoptosis , Others | |
DC_AC50 is a dual inhibitor of Atox1 and CCS (copper chaperones). Inhibiting intracellular copper chaperones as a means of reducing/preventing acquired chemotherapy resistance.DC_AC50 binding to Atox1 and CCS and reducin... | |||
T24184 | Itasetron | DAU6215CL,UNII-00S0D0OEKR,U-98079A,U 98079A,DAU 6215CL | 5-HT Receptor |
Itasetron (U 98079A) is a 5-hydroxytryptamine 3-receptor antagonist used to prevent age-related memory deficits in rats.Itasetron's antiemetic activity in animal models of cancer chemotherapy and radiation therapy may be... | |||
T3924 | Astragaloside II | Astrasieversianin VIII | TGF-beta/Smad |
Astragaloside II (Astrasieversianin VIII) is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, ... | |||
T28935 | TDRL-551 | Others | |
TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 µM) with potential anticancer activity.TDRL-551 inhibits RPA-DNA interaction and enhances the efficacy of platinum-based chemotherapy for lung... | |||
T4451 | Estramustine phosphate sodium | Ro 21-8837/001,Estramustine phosphate disodium | Apoptosis , Microtubule Associated |
Estramustine phosphate sodium (Ro 21-8837/001) is an antimicrotubule chemotherapy agent; arrests prostate cancer cells in the G2/M phase of the cell cycle. | |||
T6127 | Rucaparib Phosphate | AG-014699 phosphate,PF-01367338,AG-014699,PF-01367338 phosphate | PARP |
Rucaparib Phosphate (PF-01367338 phosphate) is an inhibitor of PARP (Ki: 1.4 nM for PARP1) that is used in clinical therapy to sensitize cancer cells to chemotherapy. | |||
T3716 | Rolapitant | SCH619734 | Neurokinin receptor |
Rolapitant (SCH619734) Hydrochloride is the hydrochloride salt form of rolapitant, an orally bioavailable, centrally-acting, selective, neurokinin 1 receptor (NK1-receptor) antagonist with potential antiemetic activity. ... | |||
T39024 | PrNMI | Cannabinoid Receptor | |
PrNMI is a highly effective and orally active agonist targeting the peripherally restricted cannabinoid 1 receptor (CB1R). It exhibits pronounced analgesic properties, efficiently suppressing both chemotherapy-induced pe... |